Fourat Ridouani1, Raphael Doustaly2, Hooman Yarmohammadi1, Stephen B Solomon1, Adrian J Gonzalez-Aguirre3. 1. Radiology Department, Interventional Radiology Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue H-118, New York , NY, USA. 2. GE Healthcare - 283 rue de la minière, Buc, France. 3. Radiology Department, Interventional Radiology Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue H-118, New York , NY, USA. gonzala2@mskcc.org.
Abstract
PURPOSE: Cone beam CT (CBCT) with planning software is used in intra-arterial liver-directed therapies. Software accuracy relies on high CBCT image quality, which can be impaired by breathing motion. We assessed the impact of a specific MCT on software performance for procedure planning and navigation. MATERIALS AND METHODS: Institutional Review Board (IRB)-approved retrospective evaluation of liver-directed therapies from July 2015 to April 2018 was performed. CBCTs with at least one well-defined tumor and noticeable breathing motion were included. Each CBCT was reconstructed with and without breathing MCT (Motion Freeze, GE Healthcare). Automatic tumor-supplying vessel detection was performed on up to 4 tumors in each CBCT reconstruction (Liver ASSIST V.I., GE Healthcare). Vessel detection sensitivity and positive predictive value (PPV) were measured with and without MCT using Digital Subtracted Angiography (DSA) as reference. Preprocedural contrast-enhanced CT was also utilized in some cases to rule out the possibility of extrahepatic supplying vessels. RESULTS: MCT was applied retrospectively to 18 CBCTs with a total of 30 tumors. At least one supplying vessel was detected for 28/30 (93%) tumors with MCT versus 20/30 (66%) without. On the subgroup of 10 CBCTs (22 tumors, 76 feeders) in which the automatic vessel detection initially worked in both reconstructions, the average sensitivity and PPV increased from 63% (48/76) and 57% (48/84) before MCT to 83% (63/76) and 79% (63/80) after (p = 0.002 and p < 0.001). CONCLUSION: Breathing MCT improves planning software performance in CBCT impaired by breathing motion.
PURPOSE: Cone beam CT (CBCT) with planning software is used in intra-arterial liver-directed therapies. Software accuracy relies on high CBCT image quality, which can be impaired by breathing motion. We assessed the impact of a specific MCT on software performance for procedure planning and navigation. MATERIALS AND METHODS: Institutional Review Board (IRB)-approved retrospective evaluation of liver-directed therapies from July 2015 to April 2018 was performed. CBCTs with at least one well-defined tumor and noticeable breathing motion were included. Each CBCT was reconstructed with and without breathing MCT (Motion Freeze, GE Healthcare). Automatic tumor-supplying vessel detection was performed on up to 4 tumors in each CBCT reconstruction (Liver ASSIST V.I., GE Healthcare). Vessel detection sensitivity and positive predictive value (PPV) were measured with and without MCT using Digital Subtracted Angiography (DSA) as reference. Preprocedural contrast-enhanced CT was also utilized in some cases to rule out the possibility of extrahepatic supplying vessels. RESULTS: MCT was applied retrospectively to 18 CBCTs with a total of 30 tumors. At least one supplying vessel was detected for 28/30 (93%) tumors with MCT versus 20/30 (66%) without. On the subgroup of 10 CBCTs (22 tumors, 76 feeders) in which the automatic vessel detection initially worked in both reconstructions, the average sensitivity and PPV increased from 63% (48/76) and 57% (48/84) before MCT to 83% (63/76) and 79% (63/80) after (p = 0.002 and p < 0.001). CONCLUSION: Breathing MCT improves planning software performance in CBCT impaired by breathing motion.
Authors: Michael J Wallace; Ravi Murthy; Paresh P Kamat; Teri Moore; Sujaya H Rao; Joe Ensor; Sanjay Gupta; Kamran Ahrar; David C Madoff; Stephen E McRae; Marshall E Hicks Journal: J Vasc Interv Radiol Date: 2007-12 Impact factor: 3.464
Authors: In Joon Lee; Jin Wook Chung; Yong Hu Yin; Hyo-Cheol Kim; Young Il Kim; Hwan Jun Jae; Jae Hyung Park Journal: J Vasc Interv Radiol Date: 2014-06-10 Impact factor: 3.464
Authors: Frederic Deschamps; Stephen B Solomon; Raymond H Thornton; Pramod Rao; Antoine Hakime; Viseth Kuoch; Thierry de Baere Journal: Cardiovasc Intervent Radiol Date: 2010-12 Impact factor: 2.740